{"schema_version":"secwatch.filing_event.v1","accession":"0001185185-21-001433","form_type":"8-K","ticker":"FUST","cik":"0001636051","company_name":"FUSE GROUP HOLDING INC.","filed_at":"2021-10-01T23:59:59+00:00","discovered_at":"2026-05-14T18:04:13.421188+00:00","generated_at":"2026-06-28T23:58:57.654333+00:00","sec_items":["1.01","1.02","4.02","9.01"],"event_type":"other_material","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Fuse Group terminates E-Mo Biotech acquisition; restates Q1, Q2 2021 financials","bullets":["Terminated Share Exchange Agreement to acquire E-Mo Biotech; no shares issued or exchanged.","Will restate financials for quarters ended March 31 and June 30, 2021 due to reclassification error.","14,285,715 shares issued as prepayment for mining rights reclassified to equity deduction per SAB Topic 4:E.","Non-reliance on previously issued Q1 and Q2 2021 financial statements; amendment to 10-Qs planned."],"urls":{"canonical":"https://secwatch.observer/filing/0001185185-21-001433","json":"https://secwatch.observer/filing/0001185185-21-001433.json","markdown":"https://secwatch.observer/filing/0001185185-21-001433.md","text":"https://secwatch.observer/filing/0001185185-21-001433.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1636051/000118518521001433/0001185185-21-001433-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1636051/000118518521001433/fuseent20211001_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-28T23:58:57.654333+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}